New Report Just Published: World Multiple Myeloma Therapeutics Market Report
... Ortho Biotech Products, LP, Seattle Genetics, and ziopharm Oncology, Inc. Market data and analytics are deriv...uticals Inc, Kosan Biosciences, Ortho Biotech, ziopharm Oncology Inc and Others (includes correspondin...harmion Receives Marketing Authorization II-41 ziopharm Commences Phase II Clinical Trial of ZIO-101 II-41...ZIOPHARM Presents ZIO-201 Lymphoma Data at ISH
...01 is in advanced preclinical development. About ziopharm Oncology, Inc. ziopharm Oncology, Inc. is a biopharmaceutical company enga...s, except as required by law. ZIOP-G Contact ziopharm Oncology, Inc. Investors Suzanne McKenna, 646-...ZIOPHARM Presents Unique Mechanism Data for Indibulin at AACR
... LOS ANGELES--(BUSINESS WIRE)--Apr 16, 2007 - ziopharm Oncology, Inc. (NASDAQ: ZIOP) presented preclinica... begin phase I/II trials in the U.S. soon. About ziopharm Oncology, Inc. ziopharm Oncology, Inc. is a biopharmaceutical company enga...ZIOPHARM Presents Data on Orally Active ZIO-201 at AACR
... LOS ANGELES--(BUSINESS WIRE)--Apr 16, 2007 - ziopharm Oncology, Inc. (NASDAQ: ZIOP) announced today the ...01 is in advanced preclinical development. About ziopharm Oncology, Inc. ziopharm Oncology, Inc. is a biopharmaceutical company enga...ZIOPHARM Presents Data Highlighting Oral ZIO-101 at AACR
... LOS ANGELES--(BUSINESS WIRE)--Apr 17, 2007 - ziopharm Oncology, Inc. (NASDAQ: ZIOP) announced today the ...g cell death through this pathway as well. About ziopharm Oncology, Inc. ziopharm Oncology, Inc. is a biopharmaceutical company enga...Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
...01 is in advanced preclinical development. About ziopharm Oncology, Inc. ziopharm Oncology, Inc. is a biopharmaceutical company enga...s, except as required by law. ZIOP-G Contact ziopharm Oncology, Inc. Investors Suzanne McKenna, 646-...ZIOPHARM to Present at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
... NEW YORK--(BUSINESS WIRE)--Jul 6, 2007 - ziopharm Oncology, Inc. (NASDAQ: ZIOP) announced today that... webcast will be archived for ninety days. About ziopharm Oncology, Inc. ziopharm Oncology, Inc. applies new insights from molecular...